Fisher, Neyman, and Bayes at FDA.

J Biopharm Stat

a Department of Statistics , Harvard University, Cambridge , Massachusetts , USA.

Published: November 2017

The wise use of statistical ideas in practice essentially requires some Bayesian thinking, in contrast to the classical rigid frequentist dogma. This dogma too often has seemed to influence the applications of statistics, even at agencies like the FDA. Greg Campbell was one of the most important advocates there for more nuanced modes of thought, especially Bayesian statistics. Because two brilliant statisticians, Ronald Fisher and Jerzy Neyman, are often credited with instilling the traditional frequentist approach in current practice, I argue that both men were actually seeking very Bayesian answers, and neither would have endorsed the rigid application of their ideas.

Download full-text PDF

Source
http://dx.doi.org/10.1080/10543406.2016.1226333DOI Listing

Publication Analysis

Top Keywords

fisher neyman
4
neyman bayes
4
bayes fda
4
fda wise
4
wise statistical
4
statistical ideas
4
ideas practice
4
practice essentially
4
essentially requires
4
requires bayesian
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!